Please wait while the formulary information is being retrieved.
ZANTAC 75 (RANITIDINE HCL)
- Dyspepsia
- Heartburn
mg tablet
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
75 mg tablet
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
Dyspepsia
- 2 tablets (150 mg) by oral route every 12 hours
Heartburn
- 1 tablet (75 mg) by oral route once daily with glass of water
- 1 tablet (75 mg) by oral route 2 times per day with glass of water
- None
Contraindicated
- itraconazole
- ketoconazole
- Onmel
- Sporanox
- Sporanox Pulsepak
Severe
Moderate
- Adderall
- Adderall Xr
- Amphetamine Salt Combo
- Anti-diarrhea
- Anti-diarrheal (lope)-anti-gas
- Anti-diarrheal (loperamide)
- atazanavir
- Ceftin
- cefuroxime axetil
- Cerebyx
- Complera
- Dexedrine Spansule
- dextroamphetamine
- dextroamphetamine-amphetamine
- Diamode
- Dilantin
- Dilantin Extended
- Dilantin Infatabs
- Dilantin Kapseal
- Dilantin-125
- Edurant
- emtricitab-rilpivirine-tenofov
- ethotoin
- fosphenytoin
- Imodium Multi-symptom Relief
- Isentress
- Juxtapid
- Lo-peramide
- lomitapide
- loperamide
- loperamide-simethicone
- Peganone
- Phenytek
- phenytoin
- phenytoin sodium
- phenytoin sodium extended
- Procentra
- raltegravir
- Reyataz
- rilpivirine
- Ultra A-d
- Zenzedi
- None
Contraindicated
- Porphyria
Severe
Moderate
- Disease of liver
- Gastric cancer
- Kidney disease with reduction in GFR
ZANTAC 75 (RANITIDINE HCL)
- Dyspepsia
- Heartburn
- None
- None
More Frequent
Severe
Less Severe
- None
- Abdominal pain with cramps
- Constipation
- Diarrhea
- Dizziness
- Drowsy
- Headache disorder
- Nausea
- Skin rash
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Acute confusion
- Acute pancreatitis
- Agitation
- Agranulocytosis
- Angioedema
- Atrioventricular block
- Blurred vision
- Bradycardia
- Bronchospastic pulmonary disease
- Cardiac arrhythmia
- Depression
- Erythema multiforme
- Extrasystoles
- Fever
- Hallucinations
- Hemolytic anemia
- Hepatitis
- Hypersensitivity drug reaction
- Interstitial nephritis
- Jaundice
- Leukopenia
- Malaise
- Neutropenic disorder
- Pancytopenia
- Pneumonia
- Tachycardia
- Thrombocytopenic disorder
- Vasculitis
- Ventricular premature beats
Less Severe
- Alopecia
- Arthralgias
- Insomnia
- Myalgias
- Vertigo
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Ranitidine
- Severity Level:
B
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Ranitidine
Low amounts excreted not likely to result in infant adv effects
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Low amounts excreted not likely to result in infant adv effects |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Dyspepsia | |
| K30 | Functional dyspepsia |
| Heartburn | |
| R12 | Heartburn |
| 0-9 | A-Z |
|---|---|
| K30 | Functional dyspepsia |
| R12 | Heartburn |
Formulary Reference Tool